Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graham

Showing results (921-930 of 994) with videos related to

Pageof 100
Sort By:
Proceedings. Biological Sciences|April 19, 2013
Intraspecific morphological and genetic variation of common species predicts ranges of threatened onesTrevon L Fuller, Henri A Thomassen, Manuel Peralvo, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Genome Announcements|March 18, 2017
Genome Sequences of Mycobacteriophages Jane and Sneeze, New Members of Cluster GCatherine M Mageeney, Cimrin Bhalla, Charles A Bowman, et al.
American Journal of Human Genetics|December 19, 2020
UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidismChunmei Li, Eliane Beauregard-Lacroix, Christine Kondratev, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2022
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center ExperienceMarilyne Daher, Jeena Varghese, Stephen K Gruschkus, et al.
Lancet (London, England)|October 12, 2015
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialDiamant Thaçi, Eric L Simpson, Lisa A Beck, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2021
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic DermatitisMark Boguniewicz, Lisa A Beck, Lawrence Sher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2022
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory DiseasesG Walter Canonica, Arnaud Bourdin, Anju T Peters, et al.
The British Journal of Dermatology|October 10, 2019
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extensionM J Cork, D Thaçi, L F Eichenfield, et al.
Trials|June 26, 2016
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trialClaire A Surr, Rebecca E A Walwyn, Amanda Lilley-Kelly, et al.
Pageof 100

Showing results (921-930 of 994) with videos related to

Sort By:
Pageof 100
Proceedings. Biological Sciences|April 19, 2013
Intraspecific morphological and genetic variation of common species predicts ranges of threatened onesTrevon L Fuller, Henri A Thomassen, Manuel Peralvo, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Genome Announcements|March 18, 2017
Genome Sequences of Mycobacteriophages Jane and Sneeze, New Members of Cluster GCatherine M Mageeney, Cimrin Bhalla, Charles A Bowman, et al.
American Journal of Human Genetics|December 19, 2020
UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidismChunmei Li, Eliane Beauregard-Lacroix, Christine Kondratev, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2022
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center ExperienceMarilyne Daher, Jeena Varghese, Stephen K Gruschkus, et al.
Lancet (London, England)|October 12, 2015
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialDiamant Thaçi, Eric L Simpson, Lisa A Beck, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2021
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic DermatitisMark Boguniewicz, Lisa A Beck, Lawrence Sher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2022
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory DiseasesG Walter Canonica, Arnaud Bourdin, Anju T Peters, et al.
The British Journal of Dermatology|October 10, 2019
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extensionM J Cork, D Thaçi, L F Eichenfield, et al.
Trials|June 26, 2016
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trialClaire A Surr, Rebecca E A Walwyn, Amanda Lilley-Kelly, et al.
Pageof 100